Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Jun;40(6):794–797. doi: 10.1136/gut.40.6.794

Activation of cellular immune response in acute pancreatitis.

A Mora 1, M Pérez-Mateo 1, J A Viedma 1, F Carballo 1, J Sánchez-Payá 1, G Liras 1
PMCID: PMC1027206  PMID: 9245935

Abstract

BACKGROUND: Inflammatory mediators have recently been implicated as potential markers of severity in acute pancreatitis. AIMS: To determine the value of neopterin and polymorphonuclear (PMN) elastase as markers of activation of cellular immunity and as early predictors of disease severity. PATIENTS: Fifty two non-consecutive patients classified according to their clinical outcome into mild (n = 26) and severe pancreatitis (n = 26). METHODS: Neopterin in serum and the PMN elastase/A1PI complex in plasma were measured during the first three days of hospital stay. RESULTS: Within three days after the onset of acute pancreatitis, PMN elastase was significantly higher in the severe pancreatitis group. Patients with severe disease also showed significantly higher values of neopterin on days 1 and 2 but not on day 3 compared with patients with mild disease. There was a significant correlation between PMN elastase and neopterin values on days 1 and 2. PMN elastase on day 1 predicted disease severity with a sensitivity of 76.7% and a specificity of 91.6%. Neopterin did not surpass PMN elastase in the probability of predicting disease severity. CONCLUSIONS: These data show that activation of cellular immunity is implicated in the pathogenesis of acute pancreatitis and may be a main contributory factor to disease severity. Neopterin was not superior to PMN elastase in the prediction of severity.

Full text

PDF
794

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradley E. L., 3rd A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993 May;128(5):586–590. doi: 10.1001/archsurg.1993.01420170122019. [DOI] [PubMed] [Google Scholar]
  2. Chaloner C., Laing I., Heath D. I., Imrie C. W., Braganza J. M. Dysregulation of T cell-macrophage network in severe acute pancreatitis. Biochem Soc Trans. 1993 Nov;21(4):451S–451S. doi: 10.1042/bst021451s. [DOI] [PubMed] [Google Scholar]
  3. Domínguez-Muñoz J. E., Carballo F., García M. J., de Diego J. M., Rábago L., Simón M. A., de la Morena J. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg. 1991 Oct;78(10):1230–1234. doi: 10.1002/bjs.1800781027. [DOI] [PubMed] [Google Scholar]
  4. Formela L. J., Galloway S. W., Kingsnorth A. N. Inflammatory mediators in acute pancreatitis. Br J Surg. 1995 Jan;82(1):6–13. doi: 10.1002/bjs.1800820105. [DOI] [PubMed] [Google Scholar]
  5. Gudgeon A. M., Heath D. I., Hurley P., Jehanli A., Patel G., Wilson C., Shenkin A., Austen B. M., Imrie C. W., Hermon-Taylor J. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet. 1990 Jan 6;335(8680):4–8. doi: 10.1016/0140-6736(90)90135-r. [DOI] [PubMed] [Google Scholar]
  6. Mayer A. D., McMahon M. J., Bowen M., Cooper E. H. C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol. 1984 Feb;37(2):207–211. doi: 10.1136/jcp.37.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pacher R., Redl H., Frass M., Petzl D. H., Schuster E., Woloszczuk W. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med. 1989 Mar;17(3):221–226. doi: 10.1097/00003246-198903000-00004. [DOI] [PubMed] [Google Scholar]
  8. Puolakkainen P., Valtonen V., Paananen A., Schröder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut. 1987 Jun;28(6):764–771. doi: 10.1136/gut.28.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988 Mar;3(2-3):105–112. doi: 10.1007/BF02798921. [DOI] [PubMed] [Google Scholar]
  10. Uomo G., Spada O. A., Manes G., Feola B., Misso S., Cavallera A., Rabitti P. G. Neopterin in acute pancreatitis. Scand J Gastroenterol. 1996 Oct;31(10):1032–1036. doi: 10.3109/00365529609003125. [DOI] [PubMed] [Google Scholar]
  11. Viedma J. A., Pérez-Mateo M., Agulló J., Domínguez J. E., Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut. 1994 Jun;35(6):822–827. doi: 10.1136/gut.35.6.822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Viedma J. A., Pérez-Mateo M., Domínguez J. E., Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut. 1992 Sep;33(9):1264–1267. doi: 10.1136/gut.33.9.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wachter H., Fuchs D., Hausen A., Reibnegger G., Werner E. R. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem. 1989;27:81–141. doi: 10.1016/s0065-2423(08)60182-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES